TOBY Gains FDA Breakthrough Status for MCED Test
AUSTIN, TEXAS, USA, April 14, 2026 TOBY, Inc. has received FDA Breakthrough Device Designation for its urine-based Multi-Cancer Early...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
AUSTIN, TEXAS, USA, April 14, 2026 TOBY, Inc. has received FDA Breakthrough Device Designation for its urine-based Multi-Cancer Early...
DURHAM, N.C., April 2, 2026 restor3d, Inc., a leader in 3D-printed orthopedic medical devices, announced the full commercial release...
Atlanta, United States – March 10, 2026 Femasys Inc. has announced the initiation of patient enrollment in the FINALE...
Caesarea, Israel – March 9, 2026 A newly updated 2026 Resource Guide from the American Society of Breast Surgeons...
HAYWARD, Calif., March 4, 2026 Pulse Biosciences announced that its nPulseâ„¢ Vybranceâ„¢ System, powered by proprietary Nanosecond Pulsed Field...
February 25, 2026 – The Woodlands, Texas, USA Autonomix Medical, Inc. has announced the release of a new CEO...
STAMFORD, CT, September 25, 2025 — Apiject Systems, Corp., a leading medical technology innovator, submitted its New Drug Application...
